ARCHIVES

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

Electric Blankets May Be Risk Factor In Childhood Cancer

May 18, 1990

In Brief: Brian Henderson Names New Director Of USC Comprehensible Cancer Center, Norris Hospital

April 8, 1983

Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them

December 5, 1975

Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation

November 27, 1987

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004